Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT); cites as potential "recovery story"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. CRWD
4. AVGO
5. ULTA
6. GTLB
7. USO
8. MDT
9. GOOGL
10. VRTS

Go back to Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT); cites as potential "recovery story"
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 16.24 --0 (-0%)
Previous Close $16.24    52 Week High $63.73 
Open $16.24    52 Week Low $8.00 
Day High $16.24    P/E N/A 
Day Low $16.24    EPS $-5.69 
Volume 666